GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 165 filers reported holding GENOMIC HEALTH INC in Q2 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $23,453,000 | +0.9% | 345,813 | -13.4% | 0.04% | +4.7% |
Q2 2019 | $23,238,000 | -12.7% | 399,482 | +5.2% | 0.04% | -17.3% |
Q1 2019 | $26,612,000 | +3.6% | 379,899 | -4.8% | 0.05% | -14.8% |
Q4 2018 | $25,699,000 | -24.4% | 398,992 | -17.6% | 0.06% | -9.0% |
Q3 2018 | $33,998,000 | +37.9% | 484,161 | -1.1% | 0.07% | +34.0% |
Q2 2018 | $24,663,000 | +62.1% | 489,354 | +0.6% | 0.05% | +56.2% |
Q1 2018 | $15,216,000 | -10.7% | 486,277 | -2.4% | 0.03% | -8.6% |
Q4 2017 | $17,033,000 | -18.3% | 498,054 | -23.4% | 0.04% | -22.2% |
Q3 2017 | $20,859,000 | +13.4% | 650,000 | +15.0% | 0.04% | +4.7% |
Q2 2017 | $18,401,000 | -0.0% | 565,324 | -3.3% | 0.04% | -6.5% |
Q1 2017 | $18,406,000 | +17.9% | 584,515 | +10.0% | 0.05% | +21.1% |
Q4 2016 | $15,611,000 | -3.2% | 531,171 | -4.8% | 0.04% | -7.3% |
Q3 2016 | $16,131,000 | +1.0% | 557,770 | -9.5% | 0.04% | -4.7% |
Q2 2016 | $15,964,000 | +2.1% | 616,495 | -2.4% | 0.04% | -2.3% |
Q1 2016 | $15,639,000 | – | 631,380 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |